Nurses' communication of pharmacogenetic test results as part of discharge care

Susanne B Haga1, Rachel Mills

  • 1Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, 304 Research Drive, Box 90141, Durham, NC 27708, USA.

Pharmacogenomics
|February 26, 2015
PubMed

Insights

Pharmacogenetic (PGx) test results need clear communication pathways. We propose discussing PGx results during discharge, including them in summaries, and notifying primary providers to ensure patient understanding and optimal care.

Area of Science:

  • Clinical Pharmacy
  • Genetics in Medicine
  • Patient Communication

Background:

  • Pharmacogenetic (PGx) testing is increasingly used in hospitalized patients.
  • Effective communication of PGx results to patients is crucial for current and future healthcare decisions.
  • Current protocols for communicating PGx results during hospital stays require optimization.

Purpose of the Study:

  • To propose a framework for timely and effective communication of pharmacogenetic (PGx) test results to patients.
  • To define the roles of healthcare providers, particularly nurses, in communicating PGx findings.
  • To identify necessary educational and clinical support for healthcare professionals.

Main Methods:

  • Literature review on current pharmacogenetic testing and patient communication practices.
  • Analysis of the implications of PGx results for patient care.
  • Development of recommendations for integrating PGx result communication into clinical workflows.

Main Results:

  • Prompt discussion of PGx results upon completion of testing is ideal.
  • If not discussed promptly, results should be communicated during discharge.
  • Inclusion in discharge summaries and notification of primary providers are recommended.

Conclusions:

  • Clear communication strategies for pharmacogenetic (PGx) results are essential for patient care.
  • Nurses are vital in discharge planning and require enhanced training and support for PGx communication.
  • Revised curricula and clinical decision support tools are needed to empower nurses in this role.

Related Concept Videos

Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
1.4K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.7K
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
194
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
132
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
157
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
95